SCHEMBL86283

SCHEMBL86283

O=C1c2cc(C(F)(F)F)ccc2CSc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.43
AKR1B1 P15121 1/20 0.43
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PARP1 P09874 1/20 0.41
PARP10 Q53GL7 1/20 0.41
MAPK14 Q16539 1/20 0.41
ACHE P22303 1/20 0.40
NOTUM Q6P988 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA3 P07451 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL91673 0.86 ALDH1A1 (0.55) AKR1B1LMNAMAPK14ACHENOTUM
SCHEMBL86282 0.81 AKR1B1 (0.46) HSD17B3AKR1B1MAPK14ACHENOTUM
SCHEMBL86279 0.78 ACHE (0.59) AKR1B1LMNAMAPK14ACHENOTUM
SCHEMBL31123671 0.78 ACHE (0.59) AKR1B1LMNAMAPK14ACHENOTUM
SCHEMBL31510701 0.78 ACHE (0.59) AKR1B1LMNAMAPK14ACHENOTUM
SCHEMBL13871237 0.78 NPC1 (0.51) AKR1B1LMNAHTTNPSR1PARP1
SCHEMBL86330 0.78 TDP1 (0.59) HSD17B3AKR1B1PARP1PARP10MAPK14
SCHEMBL86749 0.78 MAOB (0.54) HSD17B3AKR1B1GAAHTTMAPK14
SCHEMBL86333 0.78 AKR1B1 (0.46) AKR1B1LMNAMAPK14ACHENOTUM
SCHEMBL86191 0.78 ELANE (0.51) HSD17B3AKR1B1HTTMAPK14ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2053095-B1 Ink composition and inkjet recording method using the same FUJIFILM CORP (JP) 2014-03-26 EP disclosed
US-8129447-B2 Ink composition and inkjet recording method using the same FUJIFILM CORPORATION (JP) 2012-03-06 US disclosed
US-8129447-B2 Ink composition and inkjet recording method using the same FUJIFILM CORPORATION (JP) 2012-03-06 US disclosed
EP-2053095-A2 Ink composition and inkjet recording method using the same Fujifilm Corporation (JP) 2009-04-29 EP disclosed
US-20090087575-A1 INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
US-20090087575-A1 INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090087575-A1 INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME RB1, IK, NOX1 HSD17B3 1694/4885AKR1B1 1704/4885LMNA 3581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.